MWNA
DRNA

Marshall Wace North America’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Marshall Wace North America’s Portfolio DRNA Stock Details DRNA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$10.3M Buy
2021
Q1 		– Sell
2020
Q4 		$394K Sell
2020
Q3 		$1.65M Buy
2020
Q2 		– Sell
2020
Q1 		$2.13M Sell
2019
Q4 		$4.67M Buy
2019
Q3 		$8K Buy
2019
Q2 		– Sell
2019
Q1 		$261K Buy
2018
Q4 		$53K Buy